MARKET

CRMD

CRMD

CORMEDIX
AMEX

Real-time Quotes | Nasdaq Last Sale

6.59
+0.15
+2.33%
After Hours: 6.55 -0.04 -0.61% 16:44 12/13 EST
OPEN
6.50
PREV CLOSE
6.44
HIGH
6.78
LOW
6.45
VOLUME
203.03K
TURNOVER
--
52 WEEK HIGH
13.70
52 WEEK LOW
4.860
MARKET CAP
169.05M
P/E (TTM)
-4.3983
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CRMD and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CRMD News

  • The future of the US wireless industry in limbo as T-Mobile and Sprint begin battle to win merger approval
  • CNBC.com.5d ago
  • Companies Like CorMedix (NYSEMKT:CRMD) Are In A Position To Invest In Growth
  • Simply Wall St..5d ago
  • 5 Safe And Cheap Dividend Stocks To Invest (December 2019)
  • Seeking Alpha - Article.6d ago
  • Top Holdings Of Dividend ETFs (Part 2: The Top 7 By Sector In November 2019)
  • Seeking Alpha - Article.6d ago

More

Industry

Pharmaceuticals
+0.14%
Pharmaceuticals & Medical Research
-0.07%

Hot Stocks

Name
Price
%Change

About CRMD

CorMedix Inc. is a commercial pharmaceutical and medical device company. The Company in-licenses, develops and commercializes prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company has in-licensed the rights to develop and commercialize its product candidate, CRMD003 (Neutrolin), which addresses market opportunities in the instances in which a central venous catheter is used, such as hemodialysis, intensive care units, oncology, and patients receiving total parenteral nutrition, intravenous (IV) hydration, and/or IV medications. Neutrolin is an anti-infective solution for the prevention of catheter-related infections and thrombosis in the central venous catheter markets, such as dialysis, critical care and oncology. Neutrolin is a broad-spectrum antimicrobial/antifungal and anticoagulant combination that is active against common microbes, including antibiotic-resistant strains, and may prevent biofilm formation.
More

Webull offers CorMedix Inc. (CRMD) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.